StoryPartnership
Insilico Medicine announces $2.75 billion AI drug discovery partnership with Eli Lilly
Insilico signed a transformative $2.75 billion agreement with Eli Lilly to use its Pharma.ai platform for discovering and developing novel drugs. The deal includes a $115 million upfront payment and demonstrates major pharmaceutical validation of AI-driven drug discovery.